Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA closed 18-22 April 2019 16 April 2019NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2019 12 April 2019NewsHumanPharmacovigilanceReferrals Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing 12 April 2019Press releaseHumanPharmacovigilanceReferrals Update of EU recommendations for 2019/2020 seasonal flu vaccine composition 12 April 2019NewsHumanVaccines The role of regulators in establishing added benefit of novel therapies 11 April 2019NewsHumanCorporateResearch and development EU recommendations for 2019/2020 seasonal flu vaccine composition 1 April 2019NewsHumanVaccines Regulatory information – 1.7% increase of fees from 1 April 2019 1 April 2019NewsCorporateFees Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 March 2019 29 March 2019NewsHumanData on medicines New gene therapy to treat rare inherited blood condition 29 March 2019Press releaseHumanData on medicines EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack 29 March 2019Press releaseHumanReferrals 1 … 101 102 103 104 105 Page 105 of 380 106 107 108 109 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2019 12 April 2019NewsHumanPharmacovigilanceReferrals
Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing 12 April 2019Press releaseHumanPharmacovigilanceReferrals
Update of EU recommendations for 2019/2020 seasonal flu vaccine composition 12 April 2019NewsHumanVaccines
The role of regulators in establishing added benefit of novel therapies 11 April 2019NewsHumanCorporateResearch and development
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 March 2019 29 March 2019NewsHumanData on medicines
New gene therapy to treat rare inherited blood condition 29 March 2019Press releaseHumanData on medicines
EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack 29 March 2019Press releaseHumanReferrals